Robert Landry

CFO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2021	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Finance and Chief Financial Officer	$822,800	—	$2,559,468	$3,839,805	$1,052,182	$24,200	$8,298,455
2020	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Finance and Chief Financial Officer	$825,577	—	$949,560	$3,459,499	$938,872	$24,195	$6,197,703
2019	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Finance and Chief Financial Officer	$730,000	—	$2,840,008	$3,526,669	$811,395	$23,470	$7,931,542
2018	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Finance and Chief Financial Officer	$680,000	—	$4,767,500	$3,308,184	$581,400	$19,535	$9,356,619
2017	Regeneron Pharmaceuticals, Inc. (REGN)	Executive Vice President, Finance and Chief Financial Officer	$618,000	—	—	$3,675,566	$482,040	$19,130	$4,794,736